- Grants since 2016
- 489
- Awarded, last 5 years (where amounts are published)
- €181.1M
- Funded works, last 5 years
- 3 159
- Funded works, all time
- 5 628
Grants
2018–2021 · fellowship · TMA
An Innovative Collaboration Model Between the National TB Control Program and Informal Healthcare Providers to Detect Additional Cases of TB In Cameroon
Sylvie Kwedi · Université de Yaoundé I
2018–2022 · fellowship · TMA
Strategies to optimize the Stability and Bio-activity of a Clinical Tuberculosis Vaccine
Babatunde Adeagbo · Obafemi Awolowo University
2018–2023 · research · RIA
MTBVAC in Newborns: Phase 2a Dose-Defining Safety and Immunogenicity Study and Capacity Building to Support Vaccine Efficacy Trials in Tuberculosis-Endemic Regions of Sub-Saharan Africa
Ingrid Murillo · Biofabri S.l.
2018–2023 · research · CSA
Strengthening the Capacity of the National Research and Ethics Review Committee and the National Regulatory Authority for Clinical Trials in Ethiopia
Yohannes Sitotaw Addisie · Federal Democratic Republic Of Ethiopia Ministry Of Education (moe)
2018–2020 · fellowship · TMA
TMA2016IF- Ahmed Zeynudin
Ahmed Zeynudin Kasim · Jimma University
2018–2023 · fellowship · TMA
The role of Mycobacterium tuberculosis compensatory mutations in metabolic fitness via the structure and function of mycolic acids
Marisa Klopper · Stellenbosch University
2018–2023 · fellowship · TMA
A randomized controlled trial of two versus three doses of Rotarix™ vaccine for boosting and longevity of vaccine immune responses in Zambia.
Roma Chilengi · Centre for Infectious Disease Research in Zambia
2018–2025 · research · RIA
Clinical development of a prophylactic vaccine for prevention of visceral leishmaniasis / post kala azar dermal leishmaniasis
Flavia D'Alessio · European Vaccine Initiative (evi) E.v.
2018–2024 · research · RIA
Improving maternal and infant health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women
Clara Menéndez · Fundación Privada Instituto De Salud Global Barcelona (isglobal)
2018–2022 · fellowship · TMA
A prospective cohort study to assess the feasibility of enrolling and retaining adolescents at risk of HIV infection from hotspots in Kampala, Uganda
Yunia Mayanja · Uganda National Health Research Organisation (unhro)
2018–2021 · fellowship · TMA
Immune responses in rural to urban gradient: Identifying geographical footprints of the immune system to improve vaccine development
Moustapha Mbow · Cheikh Anta Diop University
2018–2022 · fellowship · TMA
Inflammation, T Cell activation and Subclinical atherosclerosis in Treated HIV Infection
Tecla Temu · University of Nairobi
2018–2024 · research · RIA
Chemoprophylaxis for leprosy: comparing the effectiveness and feasibility of a skin camp intervention to a health centre based intervention. An implementation trial in Mozambique, Ethiopia and Tanzania.
Liesbeth Mieras · Nederlandse Stichting Voor Leprabestrijding (nlr)
2018–2020 · fellowship · TMA
TMA2016IF- (Shibeshi Alemayehu)
Workineh Shibeshi Alemayehu · Addis Ababa University
2018–2024 · fellowship · TMA
Strengthening Malaria Epidemiological, Pathophysiological and Intervention Studies in Highly Endemic Eastern Uganda
Peter Olupot-Olupot · Mbale Hospital
2018–2024 · research · RIA
Vulnerable populatIon TUberculosis AntiretroviraL
Catriona Waitt · University of Liverpool
2018–2021 · fellowship · TMA
Study of Pharmacogenetics of ARVs treatment outcomes in Mali, West Africa
Yaya Kassogue · Université des Sciences, des Techniques et des Technologies de Bamako
2018–2020 · fellowship · TMA
Reciever Operator Characterization of Novel EBOV/MARV-GP Epitopes using 2014-2015 Sierra Leonian Ebola Patient-Samples at the NICD BSL-IV
Misaki Wayengera · Makerere University
2018–2024 · fellowship · TMA
Evaluation of the LAMP & db-PCR-NALFIA for the Diagnosis and/or as Test-of-Cure in Patients with Visceral Leishmaniasis in Ethiopia
Dawit Wolday · Mekelle University
2018–2024 · research · RIA
Impact of increased praziquantel frequency on childhood fibrosis in persistent schistosomiasis morbidity hotspots
Shona Wilson · The Chancellor, Masters And Scholars Of The University Of Cambridge
2018–2022 · research · CSA
HATUA - Enabling Compliance And Building Capacity And Community For Clinical Research In Kenya
Elizabeth Anne Bukusi · Kenya Medical Research Institute
2018–2023 · research · RIA
Towards an arsenic-free oral treatment for human African trypanosomiasis due to Tb rhodesiense as a tool for disease elimination
Olaf Valverde Mordt · Drugs for Neglected Diseases Initiative
2018–2023 · research · RIA
Towards the interruption of transmission of soil-transmitted helminths: Clinical research development of a fixed-dose co-formulation of ivermectin and albendazole
Jose Muñoz Gutierrez · Fundación Privada Instituto De Salud Global Barcelona (isglobal)
2018–2022 · research · CSA
Translation research into policy and practice: Scaling up Evidence Based Multiple focus Integrated Intensified TB Screening to End TB (EXIT-TB) in the East African region.
Esther Ngadaya · National Institute For Medical Research - Tanzania (nimr)
2018–2024 · research · RIA
Neonatal HIV early infant diagnosis (EID) versus standard of care EID – Impact on inFant hEalth: a feasibility study of point-of care testing at birth versus at 6 weeks of age, on the uptake of ART and infant prophylaxis, and on rates of infant survival, morbidity and retention in care.
Ilesh Jani · Instituto Nacional de Saúde
2018–2021 · fellowship · TMA
Conditional economic incentives and motivational interviewing to improve adolescents’ retention and adherence to antiretroviral therapy in south-east Nigeria: a cluster randomised trial
Obinna Ekwunife · Department Of Clinical Pharmacy And Pharmacy Management - Nnamdi Azikwe University
2018–2024 · research · CSA
Pharmacovigilance infrastructure and post-marketing surveillance system capacity building for regional medicine regulatory harmonization in East Africa
Eleni Aklillu · Karolinska Institutet
2018–2024 · research · RIA
Pan-African Network For Rapid Research, Response, Relief and Preparedness for Infectious Diseases Epidemics
Francine Ntoumi · Fondation Congolaise Pour La Recherche Médicale
2018–2022 · research · CSA
Strengthening the regulatory framework to upgrade ethical review of clinical research and drugs safety monitoring in Cameroon
Jerome Ateudjieu · Ministry Of Public Health - Cameroon
2018–2022 · fellowship · TMA
Epidemiology, Diagnosis algorithms and prognostic role of Immunologic and Inflammatory Markers among HIV-2 infected individuals in West Africa
Boris Kevin Tchounga · Association Pac-ci (pacci)
2018–2024 · research · RIA
A combination efficacy study in Africa of two DNA-MVA- or DNA- Env protein HIV-1 vaccine regimens with pre-exposure prophylaxis (PrEP)
Jonathan Weber · Imperial College London
2018–2023 · research · RIA
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
Bouke De Jong · Prins Leopold Instituut Voor Tropische Geneeskunde (itm)
2018–2022 · research · CSA
Strengthening Bioethics Committees in Lusophone African Region
João Schwalbach · Comité Nacional De Bioética Para A Saúde (cnbs)
2018–2021 · fellowship · TMA
Safety and Efficacy of High Dose Rifampicin in TB-HIV co-infected patients on Efavirenz-based Antiretroviral therapy
Christine Sekaggya-Wiltshire · Infectious Diseases Institute Limited (idi)
2018–2025 · fellowship · TMA
Research Capacity Strengthening Programme for Emerging and Re emerging Infectious Diseases Control in Tanzania
Stellah George Mpagama · Kibong'oto Infectious Diseases Hospital (kidh)
2018–2021 · fellowship · TMA
Feasibility and acceptability of HIV self-testing in adolescents and young people
Grace Mchugh · Biomedical Research and Training Institute
2018–2021 · fellowship · TMA
Antiretroviral therapy Outcomes, Barriers and facilitators of Adherence among individuals initiating Treatment following Test and Start guidelines in an urban HIV clinic in Uganda
Jane Frances Namukasa Wanyama · Infectious Diseases Institute Limited (idi)
2018–2021 · fellowship · TMA
Understanding the biology of Plasmodium vivax and Plasmodium ovale for the development of a field-based anti-hypnozoite drug screening model
Laurent Dembele · Université des Sciences, des Techniques et des Technologies de Bamako
2018–2022 · research · RIA
Phase III clinical trials and registration of a new praziquantel orally disintegrating tablet formulation suitable for preschool-aged children with schistosomiasis
Remco De Vrueh · Stichting Lygature
2018–2020 · fellowship · TMA
Effects of preterm birth on HIV acquisition risk and antiretroviral prophylaxis safety in HIV-exposed infants in Botswana
Gbolahan Ajibola · Botswana Harvard AIDS Institute Partnership